Nov 11, 2021Wellcome Board AppointmentNanomerics CSO Ijeoma Uchegbu has been appointed to the board of Wellcome Ijeoma Uchegbu appointed to Wellcome board | News | Wellcome
May 23, 2021Nanomerics announces ocular progress with new patents and two key publicationsNanomerics Ltd., a world leader in molecular engineered delivery technologies, today announced the Company had been granted patent...
May 12, 2021Nanomerics CSO Prof IF Uchegbu elected to Academy of Medical SciencesToday the UK Academy of Medical Sciences announced the election of 50 new biomedical health scientists to its influential fellowship;...
Mar 23, 2021Double Milestone Payment Strengthens Nanomerics' Balance Sheet and Enables Clinical ProgramsNanomerics Ltd., a world leader in molecular engineered delivery technologies, today announced that the Company had received its first...
Dec 12, 2020Nanomerics Molecular Mask MM019 inhibits SARS-CoV-2 replicationNanomerics Molecular Mask MM019 inhibits SARS-CoV-2 replication in ex-vivo human airway epithelial air liquid interface cultures. Today...
Aug 3, 2020Nanomerics receives pIND guidance from the US FDA for NM134Today Nanomerics received supportive pIND guidance from the US FDA on the development of its asset - NM134. NM134 is indicated for the...